15.1.2024
•
News
Capital markets
KSB Drafts First EU Prospectus for Nemomax Growth Fund
A team led by Vlastimil Pihera and Josef Kříž advised real estate investment fund Nemomax on its first EU growth prospectus. With fund capital of almost one billion Czech crowns, the investment fund focuses on investments in real estate projects in the Czech Republic, mainly in the residential housing sector, and is managed by Avant, a leading Czech investment company.
Nemomax’s latest major projects include VIVA Lipno (development of apartment houses on the banks of Lipno Lake), VIVA Vrchlabí (development of 58 apartment units in the city of Vrchlabí), and development of family houses in Čimice and Bakovo.
The issuer will use the issue to finance its acquisition and development activities.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. The base prospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. The approval process was led by Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
